- Advertisement -
An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for Alzheimer’s disease.
In a new study, Northwestern scientists identified a previously unknown highly toxic sub-species of amyloid beta oligomers — toxic clusters of peptides –…
